1. Home
  2. UVV vs CDNA Comparison

UVV vs CDNA Comparison

Compare UVV & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$53.79

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$28.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
CDNA
Founded
1886
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
UVV
CDNA
Price
$53.79
$28.82
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$28.00
AVG Volume (30 Days)
298.5K
866.7K
Earning Date
05-28-2026
04-28-2026
Dividend Yield
6.25%
N/A
EPS Growth
N/A
N/A
EPS
1.30
0.05
Revenue
$2,885,078,000.00
$48,324,000.00
Revenue This Year
$0.67
$16.01
Revenue Next Year
$0.10
$11.31
P/E Ratio
$40.90
$557.00
Revenue Growth
N/A
18.93
52 Week Low
$49.19
$10.96
52 Week High
$59.38
$28.42

Technical Indicators

Market Signals
Indicator
UVV
CDNA
Relative Strength Index (RSI) 52.38 72.98
Support Level $51.57 $14.59
Resistance Level $54.14 N/A
Average True Range (ATR) 1.07 1.38
MACD 0.01 0.44
Stochastic Oscillator 72.10 89.81

Price Performance

Historical Comparison
UVV
CDNA

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: